Cannabis Government Strategies
Shaping politics & policy for the cannabis, hemp, and CBD industries
CGS – a DC-based Federal and State lobbying and consulting firm — tracking and driving conversation on Capitol Hill, at Federal Agencies, and state houses across the country.
In the News
- New Democratic Congressional Marijuana Resolution Calls For Industry Equity And Pushes Trump To Advocate For International Reform At UN
- Doctors Could Legally Administer Schedule I Drugs Like MDMA And Psilocybin To Seriously Ill Patients Under New Bipartisan Bill In Congress
- GOP Congressman Presses Federal Financial Officials On Marijuana Industry’s Banking Access Problems
- Cannabis Sales Drift Lower in November
- Researchers Published More Than 4,000 Studies On Marijuana This Year As Trump Continues To Weigh Rescheduling
- No Reason to Own Curaleaf
- Cannabist to Sell Virginia Assets to Curaleaf
- Texas Officials Finalize Medical Marijuana Rules To Let Doctors Recommend New Qualifying Conditions And Prescribe THC Inhalation Devices
- Weed Retailers Turn To Busy Holidays For Big Sales
- Cannabis Stocks Extend Decline in November
- Cannabis Consumer Survey Shows Digital Conveniences Driving Purchasing
- Oregon Cannabis: OLCC Licensing And Market Updates
- Uber's CEO Says Drivers Will Be Replaced By Robotaxis in About 10 Years: 'This Is Going to Be a Real Issue'
- Meta Is Adding AI to Facebook Dating to Help 'Anyone Tired of Swiping' Find a Better Match
- Chick-fil-A Is Opening a 'Beverage-Focused' Standalone Restaurant in a Southern State. Here's What to Expect.